Christopher Fuglesang - Net Worth and Insider Trading
Christopher Fuglesang Net Worth
The estimated net worth of Christopher Fuglesang is at least $241 Million dollars as of 2024-05-24. Christopher Fuglesang is the Director, 10% Owner of Pandion Therapeutics Inc and owns about 4,009,686 shares of Pandion Therapeutics Inc (PAND) stock worth over $241 Million. Details can be seen in Christopher Fuglesang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Fuglesang has not made any transactions after 2020-07-21 and currently still holds the listed stock(s).
Transaction Summary of Christopher Fuglesang
Christopher Fuglesang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Fuglesang owns 4 companies in total, including BCTG Acquisition Corp (BCTG) , Pandion Therapeutics Inc (PAND) , and Mirati Therapeutics Inc (MRTX) among others .
Click here to see the complete history of Christopher Fuglesang’s form 4 insider trades.
Insider Ownership Summary of Christopher Fuglesang
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCTG | BCTG Acquisition Corp | 2020-09-02 | director & President |
| PAND | Pandion Therapeutics Inc | 2020-07-21 | director & 10 percent owner |
| MRTX | Mirati Therapeutics Inc | 2023-08-11 | other: See remarks |
 | | 2020-09-02 | director & President |
Christopher Fuglesang Latest Holdings Summary
Christopher Fuglesang currently owns a total of 1 stock. Christopher Fuglesang owns 4,009,686 shares of Pandion Therapeutics Inc (PAND) as of July 21, 2020, with a value of $241 Million.
Latest Holdings of Christopher Fuglesang
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-07-21 | 4,009,686 | 60.05 | 240,781,644 |
Holding Weightings of Christopher Fuglesang
Christopher Fuglesang Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Fuglesang has made a total of 1 transactions in Pandion Therapeutics Inc (PAND) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pandion Therapeutics Inc is the acquisition of 722,222 shares on July 21, 2020, which cost Christopher Fuglesang around $13 Million.
Insider Trading History of Christopher Fuglesang
- 1
Christopher Fuglesang Trading Performance
GuruFocus tracks the stock performance after each of Christopher Fuglesang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Fuglesang is -38.63%. GuruFocus also compares Christopher Fuglesang's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Fuglesang within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Fuglesang's insider trading performs compared to the benchmark.
Performance of Christopher Fuglesang
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.94 | | | | | |
| Relative Return to S&P 500(%) | -3.35 | | | | | |
Christopher Fuglesang Ownership Network
Christopher Fuglesang Owned Company Details
What does BCTG Acquisition Corp do?
Who are the key executives at BCTG Acquisition Corp?
Christopher Fuglesang is the director & President of BCTG Acquisition Corp. Other key executives at BCTG Acquisition Corp include 10 percent owner Bctg Holdings, Llc , director & Chief Executive Officer Aaron I. Davis , and COO and Secretary Andrew Ruel Ellis .
BCTG Acquisition Corp (BCTG) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BCTG Acquisition Corp (BCTG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BCTG Acquisition Corp (BCTG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BCTG Acquisition Corp (BCTG)'s detailed insider trading history can be found in Insider Trading Tracker table.
BCTG Acquisition Corp Insider Transactions
Christopher Fuglesang Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Fuglesang. You might contact Christopher Fuglesang via mailing address: 11682 El Camino Real, Suite 320, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
